ClinVar Miner

Submissions for variant NM_004168.4(SDHA):c.1832del (p.Gln611fs)

dbSNP: rs1554002451
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000568850 SCV000664555 likely pathogenic Hereditary cancer-predisposing syndrome 2020-12-02 criteria provided, single submitter clinical testing The c.1832delA variant, located in coding exon 14 of the SDHA gene, results from a deletion of one nucleotide at nucleotide position 1832, causing a translational frameshift with a predicted alternate stop codon (p.Q611Rfs*34). This alteration occurs at the 3' terminus of theSDHA gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 54 amino acids (8.1%) of the protein. However, premature stop codons are typically deleterious in nature, and the impacted region is critical for protein function (Ambry internal data). Based on internal structural analysis, this variant also disrupts a salt-bridge which is critical to SDHA flavination (Kim HJ et al. J Biol Chem, 2012 Nov;287:40670-9; Huang S et al. Plant Signal Behav, 2013 Feb;8:e22815; Inaoka DK et al. Int J Mol Sci, 2015 Jul;16:15287-308; Starbird CA et al. J Biol Chem, 2017 08;292:12921-12933; Sharma P et al. Proc Natl Acad Sci U S A, 2020 09;117:23548-23556). In addition, the alteration has been detected in an individual with a pheochromocytoma (Ambry internal data). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Baylor Genetics RCV003476323 SCV004202919 likely pathogenic Dilated cardiomyopathy 1GG 2022-07-09 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV004787914 SCV005406045 likely pathogenic Paragangliomas 5 2024-07-18 criteria provided, single submitter clinical testing This variant is considered likely pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.